Home » Topics » BioWorld Science

BioWorld Science
RSS

Anti-CLDN18.2 BiME ES-028 shows promise as cancer immunotherapeutic

Nov. 25, 2021

Discovery of KSQ-004, a Regnase-1/SOCS1 dual-edited human CRISPR/Cas9-engineered TIL therapy

Nov. 25, 2021

Meiji Seika Pharma divulges histamine H4 receptor antagonists

Nov. 25, 2021

New PADI4 inhibitors synthesized at Gilead

Nov. 25, 2021

IL-17A/IL-17RA interaction modulators patented by Janssen Pharmaceutica

Nov. 25, 2021

New Bcl-2 inhibitors discovered at Prelude Therapeutics

Nov. 25, 2021

Pfizer describes new MAP4K1 inhibitors

Nov. 25, 2021

Adenosine A1R/A3R agonist AST-004 ameliorates brain infarction in an NHP model of stroke

Nov. 25, 2021

CDX-585, a novel bispecific antibody targeting ILT4 and PD-1 for cancer treatment

Nov. 25, 2021

Pridopidine has neuroprotective effects mediated by S1R in retinal ganglion cells of glaucoma models

Nov. 24, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...